A controlled study of a specific MAO a reversible inhibitor (R011-1163) and amitriptyline in depressive illness
- 28 February 1985
- journal article
- Published by Elsevier BV in Journal of Affective Disorders
- Vol. 8 (1), 29-35
- https://doi.org/10.1016/0165-0327(85)90069-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- L-Deprenil, A Selective Monoamine Oxidase Type B Inhibitor, in the Treatment of Depression: A Double Blind EvaluationThe British Journal of Psychiatry, 1983
- The Carroll Rating Scale for Depression I. Development, Reliability and ValidationThe British Journal of Psychiatry, 1981
- L-deprenyl, a selective monoamine oxidase type-b inhibitor in endogenous depressionLife Sciences, 1980
- Depression Rating ScalesArchives of General Psychiatry, 1973
- PLASMA CONCENTRATION OF NORTRIPTYLINE AND CLINICAL RESPONSE IN DEPRESSIVE ILLNESSThe Lancet, 1972
- Controlled Trial of Amitriptyline in General PracticeBMJ, 1971
- SEQUENTIAL COMPARISON OF L-TRYPTOPHAN WITH E.C.T. IN SEVERE DEPRESSIONThe Lancet, 1970
- A Growing Edge of Measurement of Feelings [Abridged]Proceedings of the Royal Society of Medicine, 1969
- The Diagnosis of Depressive Syndromes and the Prediction of E.C.T. ResponseThe British Journal of Psychiatry, 1965
- HYPERTENSIVE CRISIS DUE TO MONOAMINE-OXIDASE INHIBITORSThe Lancet, 1963